Christopher Paschen

Christopher Paschen

Auto-generated profile, based on publicly available information

Christopher Paschen

Department of Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Waehringer Guertel 18-20 1090 Vienna, Austria

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2024 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
FAF. Adamidis
F. Adamidis
NBN. S. Baumgartner
N. S. Baumgartner
AKAnna Kitta
Anna Kitta
LKLea Kum
Lea Kum
FEF Ecker
F Ecker
EMEva Katharina Masel
Eva Katharina Masel
Purpose: A large volume of literature suggests that timely integration of palliative care (PC) enhances the well-being, quality of life and satisfaction of patients and their families. It may also positively impact clinical outcomes and healthcare costs throughout the disease trajectory. Therefore, reviewing clinical practice to reflect real-life situations regarding timely PC integration is essential. Methods: This study, conducted at the Vienna General Hospital between March 2016 and August 2022, retrospectively examined PC consultation (PCC) requests. It aimed to assess the timeliness of PC integration by analysing the duration between diagnosis and the first PCC request, as well as the interval between the first PCC request and death. Results: This study included 895 PCCs. The median time from diagnosis to the first PCC was 16.6 (interquartile range (IQR): 3.9–48.4) months, while the median time from the first PCC to death was 17.2 (IQR: 6.1–50.7) days. The median time from diagnosis to first PCC was 10.4 months in females (confidence interval (CI): 6.0–14.8) compared to 10.6 months in males (CI: 8.1–13.1; p = 0.675). There were no gender disparities in the time from first PCC to death, with a median of 23.3 days (CI: 15.6–31.0) for females and 22.3 days (CI: 16.2–28.4) for males (p = 0.93). Fifty percent of patients died between 5 and 47 days after the first PCC. Conclusion: These findings highlight the discrepancy between the clinical perception of PC as end-of-life care and the existing literature, thereby emphasising the importance of timely PC integration.

15 February 2022 in ASAIO Journal
Verified
Journal Article
Closed access
OROliver Robak
Oliver Robak
TGTheresa Grafeneder-Weissteiner
Theresa Grafeneder-Weissteiner
PSPeter Schellongowski
Peter Schellongowski
ABAndja Bojic
Andja Bojic
CPChristopher Paschen
Christopher Paschen
TSThomas Staudinger
Thomas Staudinger
Extracorporeal lung support includes the risk of hemolysis due to suction pressures. Manufacturers measure the negative suction pressure across drainage cannulas for their products in vitro using water. Clinical experience suggests that hemolysis occurs in vivo already at much lower flow rates. The aim of this study was to analyze the in vivo suction pressure for veno-venous extracorporeal membrane oxygenation (VV-ECMO) cannulas. Prospective, observational study at a tertiary-care intensive care unit: 15 patients on VV-ECMO for severe ARDS were prospectively included. In vitro, the 25 Fr drainage cannula pressure drops below a critical level of around –100 mm Hg at a flow rate of 7.9 L/min, the 23 Fr drainage cannula at 6.6 L/min. In the clinical setting, critical suction pressures were reached at much lower flow rates (5.5 and 4.7 L/min; p < 0.0001, nonlinear regression). The in vitro data largely overestimate the safely achievable flow rates in daily clinical practice by 2.4 L/min (or 44%, 25 Fr) and 1.9 L/min (or 41%, 23 Fr). In vivo measurement of suction pressure of venous drainage cannulas differed significantly from in vitro derived measurements as the latter largely underestimate the resulting suction pressure.

1 June 2025 in Hypertension
Verified
Journal Article
Closed access
CPChristopher Paschen
Christopher Paschen
MKMaximilian Christian Koeller
Maximilian Christian Koeller
HSHelga Schachner
Helga Schachner
MNMaja Nackenhorst
Maja Nackenhorst
JKJohannes Kläger
Johannes Kläger
HRHeinz Regele
Heinz Regele
BACKGROUND: Arterial hypertension (HTN) and type 2 diabetes (T2DM) are contributors to chronic kidney disease leading to glomerulomegaly and podocyte loss. Enlarged glomeruli and podocyte depletion are associated with kidney disease progression. This retrospective study aimed to investigate morphometric changes in patients with HTN and the contribution of coexisting T2DM in HTN. METHODS: Glomerular and podocyte structure was estimated stereologically in unaffected areas of tumor nephrectomies in 99 patients. Morphometric features between subjects with HTN (n=47), HTN+T2DM (n=32), and controls without HTN and T2DM (n=20) were compared by ANOVA. Linear regression models evaluated the effect of morphometric parameters on renal compensation after nephrectomy (change of estimated glomerular filtration rate from pre-nephrectomy to 12 months post-nephrectomy). RESULTS: In total, 36% of the HTN and 50% of the patients with T2DM exhibited dipstick-positive proteinuria. Glomerular volume in HTN+T2DM was similar compared with controls (2.7±0.8 versus 2.3±0.8×10 6 µm³; P =0.16) and to HTN only (2.7±0.9×10 6 µm³; P =0.95). Podocyte density was reduced in HTN+T2DM versus controls (217±66 versus 279±75 per 10 6 µm³; P =0.02) and not different to HTN only (233±87 per 10 6 µm³; P =0.67). Podocyte nuclear volume was larger in HTN+T2DM versus controls (230±28 versus 201±32 µm³; P =0.004) and similar to HTN (221±33 µm³; P =0.39). Larger glomerular volume ( P =0.009), reduced podocyte density ( P =0.003), and nuclear hypertrophy ( P =0.01) were associated with impaired compensation. CONCLUSION: The patterns of podocyte depletion and nuclear hypertrophy were independently observed in both HTN and HTN+T2DM versus controls. Coexisting T2DM exhibited no additional contribution to glomerular and podocyte alterations.

19 June 2025 in European Journal of Internal Medicine
Verified
Journal Article
Open access
CPChristopher Paschen
Christopher Paschen
FEFranziska Ecker
Franziska Ecker
PHPatrick Haider
Patrick Haider
CWClaudia Wenzel
Claudia Wenzel
EMEva Katharina Masel
Eva Katharina Masel
Diagnosis and sex-related biases can affect clinical decision-making in serious illness, including the recognition of palliative needs. Such biases may influence when and how patients receive palliative care (PC). This study aimed to investigate differences in timing and frequency of PC consultations by diagnosis, comorbidities, age, and sex among hospitalized patients. This study retrospectively analyzed 918 patients (50.5 % female) who received a PC consultation during hospitalization between 2016 and 2022. Time from admission to first PC consultation was analyzed using a Cox proportional hazards model adjusted for primary diagnosis, comorbidities, age, and sex. Further analysis included number of follow-up consultations, time from primary disease onset to first PC consultation, and from consultation to discharge or death. Inpatients with organ failure (HR: 0.7 [95 %-CI: 0.5-0.9]; p = 0.02) or neurological diseases (HR: 0.7 [95 %-CI: 0.5-1.0]; p = 0.03) received later PC consultations than those with solid organ tumors or hematologic malignancies. Higher comorbidity burden was associated with earlier PC consultation (HR: 1.04 [CI: 1.01-1.07]; p = 0.02), while age was not linked to consultation timing (HR: 0.997 [CI: 0.992-1.002]; p = 0.20). Women received earlier PC consultations than men (HR: 1.3 [95 %-CI: 1.1-1.4]; p < 0.001). Only 9.4 % of individuals received a follow-up consultation, with the lowest proportion in subjects with organ failure (4.7 %). This study highlights earlier PC consultation requests during hospitalization for individuals with malignant diseases and for women. The low rate of follow-up PC consultations indicates that the importance of regular PC involvement to improve patient's outcomes still did not permeate into clinical practice.

22 June 2023 in Head & Neck
Verified
Journal Article
Open access
CPChristopher Paschen
Christopher Paschen
MMMatthias Moll
Matthias Moll
GAGabriela Altorjai
Gabriela Altorjai
MHManfred Hecking
Manfred Hecking
TFThorsten Fuereder
Thorsten Fuereder
HHHarald Herrmann
Harald Herrmann
Objective: Nephrotoxicity is frequent in cisplatin‐based chemoradiation of head and neck squamous cell carcinoma (HNSCC). Toxicity outcomes and achieved cisplatin‐doses after change of departmental hydration policy are presented.Methods: We performed a retrospective time‐series analysis of HNSCC patients undergoing chemoradiation with conventional hydration (CH) between 01/2017 and 09/2018 versus shorter hydration with mannitol (SHM) between 09/2018 and 08/2019 to compare the rate of acute kidney injury (AKI) and cumulative cisplatin dose.Results: Among 113 HNSCC patients, SHM (n = 35) in comparison to CH (n = 78) correlated with less AKI (54.3% vs. 74.4%; p = 0.034) and higher cisplatin doses (82.9% vs. 61.5% ≥200 mg/m2; p = 0.025). AKI ≥grade 2 was lower with SHM (2.9% vs. CH: 22.8%; p = 0.01). AKI occurred more frequently in females (92.6% vs. males: 60.5%, p = 0.002). Females received lower cumulative cisplatin doses (51.9% vs. males: 73.3%; p = 0.037).Conclusions: We observed less AKI and higher cumulative chemotherapy doses with SHM. Female patients were at higher risk of AKI.

30 October 2026 in Rare Disease and Orphan Drugs Journal
Verified
Journal Article
Open access
PDF file
CPChristopher Paschen
Christopher Paschen
DADaniela Allmer
Daniela Allmer
ASAlice Schmidt
Alice Schmidt
GSGere Sunder-Plassmann
Gere Sunder-Plassmann